224 related articles for article (PubMed ID: 19875458)
1. Signal transducer and activator of transcription 3 (STAT3) mediates amino acid inhibition of insulin signaling through serine 727 phosphorylation.
Kim JH; Yoon MS; Chen J
J Biol Chem; 2009 Dec; 284(51):35425-32. PubMed ID: 19875458
[TBL] [Abstract][Full Text] [Related]
2. The peroxisome proliferator-activated receptor (PPAR) β/δ agonist GW501516 inhibits IL-6-induced signal transducer and activator of transcription 3 (STAT3) activation and insulin resistance in human liver cells.
Serrano-Marco L; Barroso E; El Kochairi I; Palomer X; Michalik L; Wahli W; Vázquez-Carrera M
Diabetologia; 2012 Mar; 55(3):743-51. PubMed ID: 22179221
[TBL] [Abstract][Full Text] [Related]
3. Suppression of the mTORC1/STAT3/Notch1 pathway by activated AMPK prevents hepatic insulin resistance induced by excess amino acids.
Li H; Lee J; He C; Zou MH; Xie Z
Am J Physiol Endocrinol Metab; 2014 Jan; 306(2):E197-209. PubMed ID: 24302004
[TBL] [Abstract][Full Text] [Related]
4. Suppressor of Cytokine Signaling-3 (SOCS-3) Induces Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Expression in Hepatic HepG2 Cell Line.
Ruscica M; Ricci C; Macchi C; Magni P; Cristofani R; Liu J; Corsini A; Ferri N
J Biol Chem; 2016 Feb; 291(7):3508-19. PubMed ID: 26668321
[TBL] [Abstract][Full Text] [Related]
5. Constitutive STAT3 phosphorylation contributes to skeletal muscle insulin resistance in type 2 diabetes.
Mashili F; Chibalin AV; Krook A; Zierath JR
Diabetes; 2013 Feb; 62(2):457-65. PubMed ID: 23043161
[TBL] [Abstract][Full Text] [Related]
6. Phospho-Ser727 of STAT3 regulates STAT3 activity by enhancing dephosphorylation of phospho-Tyr705 largely through TC45.
Wakahara R; Kunimoto H; Tanino K; Kojima H; Inoue A; Shintaku H; Nakajima K
Genes Cells; 2012 Feb; 17(2):132-45. PubMed ID: 22233524
[TBL] [Abstract][Full Text] [Related]
7. Chronic tumor necrosis factor-alpha treatment causes insulin resistance via insulin receptor substrate-1 serine phosphorylation and suppressor of cytokine signaling-3 induction in 3T3-L1 adipocytes.
Ishizuka K; Usui I; Kanatani Y; Bukhari A; He J; Fujisaka S; Yamazaki Y; Suzuki H; Hiratani K; Ishiki M; Iwata M; Urakaze M; Haruta T; Kobayashi M
Endocrinology; 2007 Jun; 148(6):2994-3003. PubMed ID: 17379643
[TBL] [Abstract][Full Text] [Related]
8. Both type I and II IFN induce insulin resistance by inducing different isoforms of SOCS expression in 3T3-L1 adipocytes.
Wada T; Hoshino M; Kimura Y; Ojima M; Nakano T; Koya D; Tsuneki H; Sasaoka T
Am J Physiol Endocrinol Metab; 2011 Jun; 300(6):E1112-23. PubMed ID: 21386060
[TBL] [Abstract][Full Text] [Related]
9. Reduced phosphorylation of Stat3 at Ser-727 mediated by casein kinase 2 - protein phosphatase 2A enhances Stat3 Tyr-705 induced tumorigenic potential of glioma cells.
Mandal T; Bhowmik A; Chatterjee A; Chatterjee U; Chatterjee S; Ghosh MK
Cell Signal; 2014 Aug; 26(8):1725-34. PubMed ID: 24726840
[TBL] [Abstract][Full Text] [Related]
10. Regulation of interleukin-6-induced hepatic insulin resistance by mammalian target of rapamycin through the STAT3-SOCS3 pathway.
Kim JH; Kim JE; Liu HY; Cao W; Chen J
J Biol Chem; 2008 Jan; 283(2):708-15. PubMed ID: 17993646
[TBL] [Abstract][Full Text] [Related]
11. Amino Acids Attenuate Insulin Action on Gluconeogenesis and Promote Fatty Acid Biosynthesis via mTORC1 Signaling Pathway in trout Hepatocytes.
Dai W; Panserat S; Plagnes-Juan E; Seiliez I; Skiba-Cassy S
Cell Physiol Biochem; 2015; 36(3):1084-100. PubMed ID: 26112996
[TBL] [Abstract][Full Text] [Related]
12. Loss of Kupffer cells in diet-induced obesity is associated with increased hepatic steatosis, STAT3 signaling, and further decreases in insulin signaling.
Clementi AH; Gaudy AM; van Rooijen N; Pierce RH; Mooney RA
Biochim Biophys Acta; 2009 Nov; 1792(11):1062-72. PubMed ID: 19699298
[TBL] [Abstract][Full Text] [Related]
13. SOCS3 and SOCS6 are required for the risperidone-mediated inhibition of insulin and leptin signaling in neuroblastoma cells.
Piao L; Park J; Li Y; Shin S; Shin S; Kong G; Shrestha R; Tran Q; Hur GM; Kim JL; Park J
Int J Mol Med; 2014 May; 33(5):1364-70. PubMed ID: 24626642
[TBL] [Abstract][Full Text] [Related]
14. Effects of pioglitazone on suppressor of cytokine signaling 3 expression: potential mechanisms for its effects on insulin sensitivity and adiponectin expression.
Kanatani Y; Usui I; Ishizuka K; Bukhari A; Fujisaka S; Urakaze M; Haruta T; Kishimoto T; Naka T; Kobayashi M
Diabetes; 2007 Mar; 56(3):795-803. PubMed ID: 17327450
[TBL] [Abstract][Full Text] [Related]
15. Ciliary neurotrophic factor protects mice against streptozotocin-induced type 1 diabetes through SOCS3: the role of STAT1/STAT3 ratio in β-cell death.
Rezende LF; Santos GJ; Carneiro EM; Boschero AC
J Biol Chem; 2012 Dec; 287(50):41628-39. PubMed ID: 23038263
[TBL] [Abstract][Full Text] [Related]
16. Silencing of FGF-21 expression promotes hepatic gluconeogenesis and glycogenolysis by regulation of the STAT3-SOCS3 signal.
Wang C; Dai J; Yang M; Deng G; Xu S; Jia Y; Boden G; Ma ZA; Yang G; Li L
FEBS J; 2014 May; 281(9):2136-47. PubMed ID: 24593051
[TBL] [Abstract][Full Text] [Related]
17. IFN gamma-dependent SOCS3 expression inhibits IL-6-induced STAT3 phosphorylation and differentially affects IL-6 mediated transcriptional responses in endothelial cells.
Bluyssen HA; Rastmanesh MM; Tilburgs C; Jie K; Wesseling S; Goumans MJ; Boer P; Joles JA; Braam B
Am J Physiol Cell Physiol; 2010 Aug; 299(2):C354-62. PubMed ID: 20484656
[TBL] [Abstract][Full Text] [Related]
18. PCBP2 regulates hepatic insulin sensitivity via HIF-1α and STAT3 pathway in HepG2 cells.
Xia N; Tang Z; Wang C; Xu G; Nie X; Zhang W; Zhao Y; Wang S; Zhu X; Cui S
Biochem Biophys Res Commun; 2015 Jul 17-24; 463(1-2):116-22. PubMed ID: 26002461
[TBL] [Abstract][Full Text] [Related]
19. Egr2 enhances insulin resistance via JAK2/STAT3/SOCS-1 pathway in HepG2 cells treated with palmitate.
Lu L; Ye X; Yao Q; Lu A; Zhao Z; Ding Y; Meng C; Yu W; Du Y; Cheng J
Gen Comp Endocrinol; 2018 May; 260():25-31. PubMed ID: 28842216
[TBL] [Abstract][Full Text] [Related]
20. The Key Role of Akt Protein Kinase in Metabolic-Inflammatory Pathways Cross-Talk: TNF-α Down-Regulation and Improving of Insulin Resistance in HepG2 Cell Line.
Alipourfard I; Bakhtiyari S; Gheysarzadeh A; Di Renzo L; De Lorenzo A; Mikeladze D; Khamoushi A
Curr Mol Med; 2021; 21(3):257-264. PubMed ID: 32338219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
